Last reviewed · How we verify
Nisreen Ibrahim khan — Portfolio Competitive Intelligence Brief
3 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Nano Silver Fluoride varnish | Nano Silver Fluoride varnish | marketed | ||||
| nano-hydroxyapatite varnish | nano-hydroxyapatite varnish | marketed | Remineralizing agent | Tooth enamel (hydroxyapatite crystal structure) | Dentistry / Oral Health | |
| sodium Fluoride Varnish | sodium Fluoride Varnish | marketed | Topical fluoride agent | Hydroxyapatite in tooth enamel and dentin; bacterial glycolytic enzymes | Dentistry / Preventive Oral Health |
Therapeutic area mix
- Dentistry / Oral Health · 1
- Dentistry / Preventive Oral Health · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Ain Shams University · 1 shared drug class
- CareQuest Institute for Oral Health · 1 shared drug class
- Gaba International AG · 1 shared drug class
- GlaxoSmithKline · 1 shared drug class
- Hadassah Medical Organization · 1 shared drug class
- King Abdulaziz University · 1 shared drug class
- Procter and Gamble · 1 shared drug class
- Riyadh Colleges of Dentistry and Pharmacy · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Nisreen Ibrahim khan:
- Nisreen Ibrahim khan pipeline updates — RSS
- Nisreen Ibrahim khan pipeline updates — Atom
- Nisreen Ibrahim khan pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Nisreen Ibrahim khan — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/nisreen-ibrahim-khan. Accessed 2026-05-16.